Health Trials

T - Cell Lymphoma

2

Review clinical trials related to T - Cell Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL

To observe the safety and efficacy of Nanobody-Based CD5-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed T-ALL/NHL

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 3-70Biological sex: AllType: InterventionalSponsor: Peking University People's HospitalUpdated: May 7, 2026Locations: 1
Eligibility criteria

The subject or guardian understands and voluntarily signs the informed consent f... [+13]

Epilepsy [+45]

Read more
Status: Recruiting

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL

Participants needed: 50
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Aug 6, 2025Locations: 1
Eligibility criteria

With the subject's consent and having signed the informed consent form, willing... [+5]

History of allergy to any of the components in the cell product; [+7]

Read more